Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological Intensification Strategies in Highly Refractory Obsessive-Compulsive Disorder: Evidence Synthesis and a Tertiary-Care Case Series.

Journal of clinical medicine·2026
Same author

Correction: A narrative review on trazodone as a multimodal and multifunctional antidepressant: clinical relevance of formulations, dosing, and pharmacokinetic/pharmacodynamic targets.

Annals of general psychiatry·2026
Same author

Initiation of aripiprazole once-monthly via a two‑injection start in adult patients diagnosed with schizophrenia: real-world experiences of healthcare professionals from five European countries.

Annals of general psychiatry·2026
Same author

Risperidone long-acting in-situ microimplant following a brief oral risperidone lead-in in the acute inpatient management of manic episodes with psychotic symptoms in non-adherent patients with schizoaffective disorder: a retrospective, uncontrolled real-world study.

Annals of general psychiatry·2026
Same author

Rehabilitation in Adults with Complex Psychosis: A Clinician-Oriented Narrative Review of Multidimensional Approaches to Functional Recovery.

Medicina (Kaunas, Lithuania)·2026
Same author

The Monoamine-Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Videos

Inflammation, serotonin and major depression.

Mario Catena-Dell'Osso1, Francesco Rotella, Adriana Dell'Osso

  • 1Department of Clinical and Experimental Medicine, University of Pisa, via Roma 67, Pisa, Italy. catena.mario@virgilio.it

Current Drug Targets
|March 28, 2013
PubMed
Summary
This summary is machine-generated.

Major depressive disorder (MDD) may involve inflammation, not just serotonin. Stress-induced cytokines activate pathways that reduce tryptophan and serotonin, suggesting new treatment targets beyond traditional monoamine antidepressants.

Related Experiment Videos

Area of Science:

  • Neurobiology
  • Psychiatry
  • Immunology

Background:

  • Major depressive disorder (MDD) pathophysiology is actively researched.
  • Historically, monoamine neurotransmission, particularly serotonin (5-HT), was the primary focus.
  • Inconclusive data on monoamine alterations and limited efficacy of related antidepressants necessitate exploring alternative mechanisms.

Purpose of the Study:

  • To investigate the role of inflammatory pathways in MDD.
  • To explore the cytokine hypothesis of MDD.
  • To identify novel molecular mechanisms for MDD pathophysiology and treatment.

Main Methods:

  • Review of current scientific literature on MDD pathophysiology.
  • Analysis of the cytokine hypothesis and its proposed mechanisms.
  • Examination of the indoleamine 2,3 dioxygenase (IDO) pathway and tryptophan (TRP) catabolites (TRYCATs).

Main Results:

  • Evidence suggests inflammatory pathways play a significant role in MDD.
  • Stress-related cytokine production (interleukins, TNF-α, IFN-α/γ) is implicated.
  • Cytokines activate the IDO pathway, leading to decreased TRP and 5-HT availability.

Conclusions:

  • Inflammation, via the cytokine-IDO-TRYCAT pathway, is a key factor in MDD.
  • MDD pathophysiology involves more than just monoamine alterations.
  • Targeting inflammatory pathways offers potential for improved MDD treatment strategies.